Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol

J Diaz, OJ Escalona, NC Castro, JMCC Anderson, BM Glover, G Manoharan

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The most common strategies in the managementof atrial fibrillation (AF) involve electrical cardioversion andpharmacological agents. Bisoprolol is a high selective β1-adrenoceptor blocker used for ventricular rate control and tohelp maintain sinus rhythm. In a retrospective study we comparedECG frequency domain variables between patients whounderwent a successful electrical cardioversion and those thatwere unsuccessful. As well as this we assessed whether therewas a difference in these variables for patients who underwent electrical cardioversion while on bisoprolol. Signal processingwas performed on 51 patients undergoing electrical cardioversion:bandpass filtering (0.5-50Hz), QRST cancellation andfrequency analysis. An incremental defibrillation energy protocolwas delivered until cardioversion or up to a maximumlevel of 200 [J]. The study indicated a significant difference inthe dominant AF frequency for long segments (DAFF_L) betweencardioverted and non-cardioverted subgroups, employingan energy less or equal to 100 Joules respectively: (5.5391 ±1.0396) [Hz] vs. (6.0859 ±0.8071) [Hz] (n=48, p = 0.048), and inpatients on bisoprolol: (5.5250 ±1.0302) [Hz] vs. (6.4489±0.5828) [Hz] (n=26, p = 0.008). Also, the energy required forsuccessful cardioversion was significantly lower for patients onbisoprolol: (110.00 ± 27.77) [J] vs. (129.41 ±30.92) [J], p=0.046.Also, there was a positive correlation between the DAFF_Land the minimal energy necessary for successful cardioversion( =0.434, p=0.007); a better correlation was obtained for patientson bisoprolol ( =0.575, p=0.005). Therefore, analysis ofDAFF_L on Lead II can be a useful indicator for predictingdefibrillation success in AF patients undergoing transthoracicelectric cardioversion, and there is a positive incidence of Bisoprololupon the values of DAFF_L and electrical cardioversionsuccess at minimal shock energy.
LanguageEnglish
Title of host publicationUnknown Host Publication
Pages722-725
Number of pages4
Publication statusPublished - 2009
EventThe World Congress on Medical Physics and Biomedical Engineering, 2009. - Munich, Germany
Duration: 1 Jan 2009 → …

Conference

ConferenceThe World Congress on Medical Physics and Biomedical Engineering, 2009.
Period1/01/09 → …

Fingerprint

Bisoprolol
Electric Countershock
Atrial Fibrillation
Adrenergic Receptors
Inpatients
Retrospective Studies

Keywords

  • Atrial fibrillation cardioversion
  • atrial fibrillatory frequency
  • Bisoprolol effects
  • QRS complex cancellation

Cite this

Diaz, J., Escalona, OJ., Castro, NC., Anderson, JMCC., Glover, BM., & Manoharan, G. (2009). Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol. In Unknown Host Publication (pp. 722-725)
Diaz, J ; Escalona, OJ ; Castro, NC ; Anderson, JMCC ; Glover, BM ; Manoharan, G. / Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol. Unknown Host Publication. 2009. pp. 722-725
@inproceedings{97014e58df654ad1b42b560f88061920,
title = "Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol",
abstract = "The most common strategies in the managementof atrial fibrillation (AF) involve electrical cardioversion andpharmacological agents. Bisoprolol is a high selective β1-adrenoceptor blocker used for ventricular rate control and tohelp maintain sinus rhythm. In a retrospective study we comparedECG frequency domain variables between patients whounderwent a successful electrical cardioversion and those thatwere unsuccessful. As well as this we assessed whether therewas a difference in these variables for patients who underwent electrical cardioversion while on bisoprolol. Signal processingwas performed on 51 patients undergoing electrical cardioversion:bandpass filtering (0.5-50Hz), QRST cancellation andfrequency analysis. An incremental defibrillation energy protocolwas delivered until cardioversion or up to a maximumlevel of 200 [J]. The study indicated a significant difference inthe dominant AF frequency for long segments (DAFF_L) betweencardioverted and non-cardioverted subgroups, employingan energy less or equal to 100 Joules respectively: (5.5391 ±1.0396) [Hz] vs. (6.0859 ±0.8071) [Hz] (n=48, p = 0.048), and inpatients on bisoprolol: (5.5250 ±1.0302) [Hz] vs. (6.4489±0.5828) [Hz] (n=26, p = 0.008). Also, the energy required forsuccessful cardioversion was significantly lower for patients onbisoprolol: (110.00 ± 27.77) [J] vs. (129.41 ±30.92) [J], p=0.046.Also, there was a positive correlation between the DAFF_Land the minimal energy necessary for successful cardioversion( =0.434, p=0.007); a better correlation was obtained for patientson bisoprolol ( =0.575, p=0.005). Therefore, analysis ofDAFF_L on Lead II can be a useful indicator for predictingdefibrillation success in AF patients undergoing transthoracicelectric cardioversion, and there is a positive incidence of Bisoprololupon the values of DAFF_L and electrical cardioversionsuccess at minimal shock energy.",
keywords = "Atrial fibrillation cardioversion, atrial fibrillatory frequency, Bisoprolol effects, QRS complex cancellation",
author = "J Diaz and OJ Escalona and NC Castro and JMCC Anderson and BM Glover and G Manoharan",
year = "2009",
language = "English",
pages = "722--725",
booktitle = "Unknown Host Publication",

}

Diaz, J, Escalona, OJ, Castro, NC, Anderson, JMCC, Glover, BM & Manoharan, G 2009, Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol. in Unknown Host Publication. pp. 722-725, The World Congress on Medical Physics and Biomedical Engineering, 2009., 1/01/09.

Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol. / Diaz, J; Escalona, OJ; Castro, NC; Anderson, JMCC; Glover, BM; Manoharan, G.

Unknown Host Publication. 2009. p. 722-725.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol

AU - Diaz, J

AU - Escalona, OJ

AU - Castro, NC

AU - Anderson, JMCC

AU - Glover, BM

AU - Manoharan, G

PY - 2009

Y1 - 2009

N2 - The most common strategies in the managementof atrial fibrillation (AF) involve electrical cardioversion andpharmacological agents. Bisoprolol is a high selective β1-adrenoceptor blocker used for ventricular rate control and tohelp maintain sinus rhythm. In a retrospective study we comparedECG frequency domain variables between patients whounderwent a successful electrical cardioversion and those thatwere unsuccessful. As well as this we assessed whether therewas a difference in these variables for patients who underwent electrical cardioversion while on bisoprolol. Signal processingwas performed on 51 patients undergoing electrical cardioversion:bandpass filtering (0.5-50Hz), QRST cancellation andfrequency analysis. An incremental defibrillation energy protocolwas delivered until cardioversion or up to a maximumlevel of 200 [J]. The study indicated a significant difference inthe dominant AF frequency for long segments (DAFF_L) betweencardioverted and non-cardioverted subgroups, employingan energy less or equal to 100 Joules respectively: (5.5391 ±1.0396) [Hz] vs. (6.0859 ±0.8071) [Hz] (n=48, p = 0.048), and inpatients on bisoprolol: (5.5250 ±1.0302) [Hz] vs. (6.4489±0.5828) [Hz] (n=26, p = 0.008). Also, the energy required forsuccessful cardioversion was significantly lower for patients onbisoprolol: (110.00 ± 27.77) [J] vs. (129.41 ±30.92) [J], p=0.046.Also, there was a positive correlation between the DAFF_Land the minimal energy necessary for successful cardioversion( =0.434, p=0.007); a better correlation was obtained for patientson bisoprolol ( =0.575, p=0.005). Therefore, analysis ofDAFF_L on Lead II can be a useful indicator for predictingdefibrillation success in AF patients undergoing transthoracicelectric cardioversion, and there is a positive incidence of Bisoprololupon the values of DAFF_L and electrical cardioversionsuccess at minimal shock energy.

AB - The most common strategies in the managementof atrial fibrillation (AF) involve electrical cardioversion andpharmacological agents. Bisoprolol is a high selective β1-adrenoceptor blocker used for ventricular rate control and tohelp maintain sinus rhythm. In a retrospective study we comparedECG frequency domain variables between patients whounderwent a successful electrical cardioversion and those thatwere unsuccessful. As well as this we assessed whether therewas a difference in these variables for patients who underwent electrical cardioversion while on bisoprolol. Signal processingwas performed on 51 patients undergoing electrical cardioversion:bandpass filtering (0.5-50Hz), QRST cancellation andfrequency analysis. An incremental defibrillation energy protocolwas delivered until cardioversion or up to a maximumlevel of 200 [J]. The study indicated a significant difference inthe dominant AF frequency for long segments (DAFF_L) betweencardioverted and non-cardioverted subgroups, employingan energy less or equal to 100 Joules respectively: (5.5391 ±1.0396) [Hz] vs. (6.0859 ±0.8071) [Hz] (n=48, p = 0.048), and inpatients on bisoprolol: (5.5250 ±1.0302) [Hz] vs. (6.4489±0.5828) [Hz] (n=26, p = 0.008). Also, the energy required forsuccessful cardioversion was significantly lower for patients onbisoprolol: (110.00 ± 27.77) [J] vs. (129.41 ±30.92) [J], p=0.046.Also, there was a positive correlation between the DAFF_Land the minimal energy necessary for successful cardioversion( =0.434, p=0.007); a better correlation was obtained for patientson bisoprolol ( =0.575, p=0.005). Therefore, analysis ofDAFF_L on Lead II can be a useful indicator for predictingdefibrillation success in AF patients undergoing transthoracicelectric cardioversion, and there is a positive incidence of Bisoprololupon the values of DAFF_L and electrical cardioversionsuccess at minimal shock energy.

KW - Atrial fibrillation cardioversion

KW - atrial fibrillatory frequency

KW - Bisoprolol effects

KW - QRS complex cancellation

M3 - Conference contribution

SP - 722

EP - 725

BT - Unknown Host Publication

ER -

Diaz J, Escalona OJ, Castro NC, Anderson JMCC, Glover BM, Manoharan G. Predicting Successful Transthoracic Cardioversion by Dominant Atrial Fibrillatory Frequency Analysis: The Effects of Bisoprolol. In Unknown Host Publication. 2009. p. 722-725